India’s SRL Ranbaxy Said Merging With Religare Wellness
This article was originally published in PharmAsia News
Executive Summary
Diagnostics maker SRL Ranbaxy is considering a merger with drug retailer Fortis HealthWorld before it makes an initial public offering, an effort to increase its value, according to an insider. Fortis HealthWorld just recently changed its name to Religare Wellness as part of an earlier rearrangement, and a Religare spokesman said, "there are no merger plans as of today." SRL, owned by Ranbaxy Laboratories, has a chain of pathological laboratories in India, and a merger with Religare would increase its IPO value by tying it with the latter's technology services and outsourcing business. (Click here for more
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.